Navigation Links
Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
Date:4/8/2008

Model Created Using Piecewise Smooth Subdivision Surface Provides Both

Shape and Volumetric Evaluation of Tetralogy of Fallot Patients

SEATTLE, April 8, 2008 /PRNewswire/ -- Three dimensional visualization of the right ventricle provides important shape and volumetric insights that help cardiologists diagnose and treat patients with tetralogy of Fallot (TOF), according to a paper published in the American Journal Cardiology (2008; Vol. 101, Issue 1, 107-113).

TOF is a disease that impacts the heart in multiple ways, such as creating a hole between the ventricles and developing levels of obstruction from the right ventricle to the lungs known as pulmonary stenosis. The three dimensional models created in the study provided volumetric data that was used to determine that patients with TOF had dilated right ventricles compared to individuals with normal function (end-diastolic volume index 216+/- 99 vs 81 +/- 16 ml/mm, p <0.001). The three dimensional models also provided an understanding of changes to the shape of the right ventricle that doctors can use to analyze how the heart adapts to hemodynamic overload.

Entitled "Three-Dimensional Analysis of Right Ventricular Remodeling in Repaired Tetralogy of Fallot," the paper was authored by Dr. Florence H. Sheehan, M.D. The research was a collaboration between investigators at Texas Children's Hospital, Oregon Health & Science University, University of Iowa, and University of Washington in Seattle, Wash. The study used piecewise smooth subdivision reconstruction to create three dimensional models of the hearts of 8 normal subjects and 15 patients with repaired TOF.

"Right ventricle measurement is a critical component in understanding the effectiveness of TOF repair," said Dr. Florence Sheehan, M.D., who is a professor at the University of Washington and chief scientist of VentriPoint Diagnostics Ltd. "We hope to now fully develop the novel diagnostic tools that make the process of accurately obtaining this information easier and much quicker."

Researchers apply the piecewise smooth subdivision surface method by tracing heart borders from many two dimensional images of a heart. VentriPoint Diagnostics is developing a new product, the VentriPoint Diagnostic System (VDS), that enables a similar analysis after a medical professional enters a small number of anatomical points on the heart images. The VDS uses Knowledge Based Reconstruction to automatically compare the points to a database and generate a three dimensional model. This model provides volumetric and anatomical data for the cardiologist.

"The VentriPoint Diagnostic System's ability to rapidly and easily provide right ventricle measurement in multiple disease areas, including tetralogy of Fallot, shows us that this technology will have broad potential once fully developed," said Joseph Ashley, CEO of VentriPoint Diagnostics. "Based on results similar to these from our working prototype, we hope to move into beta testing later this year."

About VentriPoint Diagnostics

VentriPoint creates diagnostic tools to monitor patients with heart disease - the number one cause of death in developed countries. Its lead technology, the VentriPoint Diagnostic System, improves existing medical imaging systems to rapidly and cost effectively obtain measurements that are critical but currently unavailable. Through its technology license and research and development agreements with the University of Washington, VentriPoint is developing this breakthrough diagnostic tool that can provide measurement of a heart's volume and ventricular ejection fraction. The VentriPoint Diagnostic System, together with its associated online service, is being developed for a variety of heart related disease states, including congenital heart disease.

For further information, please contact:

Edward Garth, Chief Financial Officer

VentriPoint Diagnostics Ltd.

Telephone: (206) 283-0221, ext. 402

Facsimile: (206) 283-2309

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

VentriPoint Media Contacts:

Russo Partners LLC

Ian Stone

(619) 814-3510

ian.stone@russopartnersllc.com


'/>"/>
SOURCE VentriPoint Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico
2. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
3. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
4. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
5. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
6. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
7. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
8. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
9. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
10. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
11. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition ... Industry Forecast to 2025" report to their offering. ... The Global Wireless Health ... over the next decade to reach approximately $330.5 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:2/24/2017)... , Feb 24, 2017 Research and Markets has ... - 2016" report to their offering. ... The latest research Hemophilia Drugs Price Analysis and Strategies ... market. The research answers the following questions: ... attributes? How are they positioned in the Global Hemophilia market? ...
(Date:2/24/2017)... Feb. 24, 2017  In conjunction with DURECT Corporation,s ... results press release, you are invited to listen to ... the internet on Tuesday, March 14, 2017 at 4:30 ... A live audio webcast of the presentation will be ... and clicking "Investor Relations."  If you are unable to ...
Breaking Medicine Technology:
(Date:2/24/2017)... , ... February 24, 2017 , ... An in-depth computational ... the University of Pittsburgh points to eight genes that may explain why susceptibility to ... to the results of a study published today in the journal npj Schizophrenia. ...
(Date:2/24/2017)... ... ... Smart Machine Age is here, and it’s disrupting everything. Not only could it drive ... United States may be taken over by technology in the next five to fifteen ... colleagues is drawing to a close. Success will belong to those who can quiet ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... disabilities, it is so critically important that we all are aware of our ... why Mediaplanet is proud to announce the launch of its newest edition of ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal ... Schanssema ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, ... his attempts to overcome them. , Schanssema, initially unsure of the career path he ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University Institute for Palliative ... in or interested in palliative care education and research. The Symposium, “Innovate. Investigate. ... County San Diego on Sept. 28 and 29, 2017, on the campus of California ...
Breaking Medicine News(10 mins):